Moneycontrol PRO
HomeNewsGlenmarkpharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Sell Glenmark Pharma, says CA Rudramurthy BV

    CA Rudramurthy BV of Vachana Investments recommmends selling Glenmark Pharma as the stock may test Rs 730.

  • Exit Marksans Pharma, says Vijay Chopra

    Exit Marksans Pharma, says Vijay Chopra

    Vijay Chopra of enochventures.com is of the view that one may exit Marksans Pharma.

  • Like Sun Pharma, Cipla, Glenmark Pharma: Deven Choksey

    Like Sun Pharma, Cipla, Glenmark Pharma: Deven Choksey

    Deven Choksey of KRChoksey Invst Managers likes Sun Pharmaceutical Industries, Cipla and Glenmark Pharma from the pharma space.

  • Short Bharat Electronics, NMDC: Sudarshan Sukhani

    Short Bharat Electronics, NMDC: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com recommends shorting Bharat Electronics Limited and NMDC.

  • Go long in Dish TV, sell PTC India: Prakash Gaba

    Go long in Dish TV, sell PTC India: Prakash Gaba

    Prakash Gaba of prakashgaba.com recommends going long in Dish TV and advises selling PTC India.

  • Sell Glenmark Pharma, says Sudarshan Sukhani

    Sell Glenmark Pharma, says Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one may sell Glenmark Pharma.

  • Sell pharma stocks; buy Hero Moto, Power Grid: Sudarshan Sukhani

    Sell pharma stocks; buy Hero Moto, Power Grid: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com recommends selling pharma stocks and advises buying Hero Motocorp and Power Grid.

  • Short PNB, Lupin; Britannia may test Rs 2,550: Prakash Gaba

    Short PNB, Lupin; Britannia may test Rs 2,550: Prakash Gaba

    Prakash Gaba of prakashgaba.com is of the view that one may short Punjab National Bank and Lupin and feels that Britannia Industries may test Rs 2,550.

  • Like Glenmark Pharma, Sun Pharma: Deven Choksey

    Like Glenmark Pharma, Sun Pharma: Deven Choksey

    Deven Choksey of KRChoksey Investment Managers likes Glenmark Pharma and Sun Pharma.

  • Buy Ashok Leyland, Aurobindo Pharma, HDIL, UPL: Ashwani Gujral

    Buy Ashok Leyland, Aurobindo Pharma, HDIL, UPL: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Ashok Leyland and Aurobindo Pharma.

  • Buy Glenmark Pharma, Jubilant Food, LIC Housing: Ashwani Gujral

    Buy Glenmark Pharma, Jubilant Food, LIC Housing: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Glenmark Pharma, Jubilant Foodworks and LIC Housing Finance.

  • Sell Marico, NCC; buy Tata Steel: Ashwani Gujral

    Sell Marico, NCC; buy Tata Steel: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends selling Marico and NCC and advises buying Tata Steel.

  • Sell Glenmark Pharma, DHFL; buy Tech Mahindra: Ashwani Gujral

    Sell Glenmark Pharma, DHFL; buy Tech Mahindra: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends selling Glenmark Pharma and DHFL and advises buying Tech Mahindra.

  • Prefer Aurobindo, Ajanta Pharma, Torrent Pharma: Gujral

    Prefer Aurobindo, Ajanta Pharma, Torrent Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one may prefer Aurobindo Pharma, Ajanta Pharma and Torrent Pharma and likes Glenmark Pharma.

  • Buy Lupin, Glenmark Pharma, Wockhardt: SP Tulsian

    Buy Lupin, Glenmark Pharma, Wockhardt: SP Tulsian

    SP Tulsian of sptulsian.com recommends buying Lupin, Glenmark Pharma and Wockhardt.

  • Buy Bata India; sell Glenmark, SAIL: Sudarshan Sukhani

    Buy Bata India; sell Glenmark, SAIL: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com recommends buying Bata India and advises selling Glenmark and SAIL.

  • Like Aurobindo Pharma, Glenmark Pharma: SP Tulsian

    Like Aurobindo Pharma, Glenmark Pharma: SP Tulsian

    SP Tulsian of sptulsian.com likes Aurobindo Pharma and Glenmark Pharma.

  • Sell Tata Steel, Glenmark; buy Asian Paints: Sudarshan Sukhani

    Sell Tata Steel, Glenmark; buy Asian Paints: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one may buy Asian Paints.

  • Bull's Eye: Buy Jet, Gati, IDFC Bank, UBL; sell Wockhardt

    Bull's Eye: Buy Jet, Gati, IDFC Bank, UBL; sell Wockhardt

    Gaurav Ratnaparkhi of Sharekhan advises buying Federal Bank with a target of Rs 49.20.

  • Positive on Aurobindo Pharma; look at Glenmark, Lupin: Tulsian

    Positive on Aurobindo Pharma; look at Glenmark, Lupin: Tulsian

    SP Tulsian of sptulsian.com has a positive view on Aurobindo Pharma and feels that one can look at Glenmark Pharma and Lupin.

  • Bull's Eye: Buy PNB, IRB Infra, HDIL, SAIL, Ceat, CESC, Godrej

    Bull's Eye: Buy PNB, IRB Infra, HDIL, SAIL, Ceat, CESC, Godrej

    Gaurav Ratnaparkhi of Sharekhan suggests buying Bharat Forge with a target of Rs 875.

  • Six stocks that should do well today

    Six stocks that should do well today

    Manas Jaiswal of manasjaiswal.com suggests selling Glenmark Pharma with a target of Rs 700.

  • Glenmark may test Rs 1186; look at UltraTech, Infosys: Bodke

    Glenmark may test Rs 1186; look at UltraTech, Infosys: Bodke

    Ajay Bodke of Prabhudas Lilladher feels that Glenmark Pharma may move to Rs 1186.

  • JSW Steel may test Rs 1000: SP Tulsian

    JSW Steel may test Rs 1000: SP Tulsian

    SP Tulsian of sptulsian.com is of the view that JSW Steel may test Rs 1000.

  • Buy Glenmark Pharma; like Lupin, Dr Reddy's Lab: Abhishek Sharma

    Buy Glenmark Pharma; like Lupin, Dr Reddy's Lab: Abhishek Sharma

    Abhishek Sharma, Pharma Analyst at IIFL recommends buying Glenmark Pharma and likes Lupin and Dr Reddy's Labs.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347